Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRO
Biotech
Merck turns to Acclinate to boost diversity of cancer trials
Merck & Co. has teamed up with Alabama-based Acclinate to try and enroll more African American patients in its cancer drug studies.
James Waldron
Nov 30, 2023 8:58am
QuantHealth debuts AI-based program to simulate trials at scale
Nov 29, 2023 10:31pm
RetinAI Medical joins non-profit macular degeneration initiative
Nov 29, 2023 11:36am
BioVie blames trial sites for phase 3 Alzheimer’s drug fail
Nov 29, 2023 10:05am
Could a CRO error explain Acelyrin's shocking phase 3 failure?
Nov 28, 2023 5:00am
Fortrea, Medidata ink deal to drive diversity in trials
Nov 21, 2023 10:10am
